History
Aedes SIIQ was created following the demerger of the pre-existing Aedes (now called Restart), founded in 1905 and listed on the Italian Stock Exchange since 1924. Aedes SIIQ, following the demerger – approved in the Shareholders’ Meeting of September 27, 2018 – and simultaneous listing on the MTA market managed by Borsa Italiana in December 2018, owns a real estate rent portfolio and development for rent portfolio in line with the strategy of a REIT with commercial purpose (Retail and Office).
Strategy and Mission
Aedes SIIQ’s strategy consists of the creation and expansion of its “Commercial Portfolio”, with a particular focus on new-generation “Retail Properties” and high-quality “Office Spaces” exceeding the industry average, in order to generate recurring cash flows in line with the SIIQ/REIT model.
The recurring cash flow will derive both from the properties already owned, with retail and office use, currently leased or in the marketing phase, and from the areas that will be developed in-house to realize rental properties primarily for retail purposes.
Aedes SIIQ is building its future thanks to the investments of its two business lines, acquiring income properties to compete with the performances of European REITs and, on the other, creating a new generation of shopping and leisure centers through its pipeline development, with a limited recourse to both indebtedness and financial risk assumptions.
Shareholding
Below is the list of Shareholders who hold a stake of more than 3% (taking into account the Issuer’s qualification as a SME pursuant to Article 1, paragraph 1, letter w-quater. 1, of the TUF and the provisions of Consob resolution no.37 of 7 August 2020, as well as by Consob resolution no. 21672 of January 13, 2021 which extended Consob resolutions no. 21326 and 21327 of 9 April 2020) resulting from the Consob communications received pursuant to art . 120 of the Consolidated Law, as well as other information available to the Company.
* It should be noted that Augusto S.p.A. holds an equity investment equal to 47.45% of the total share capital of Aedes SIIQ S.p.A., of which n. 13,678,083 ordinary shares (equal to 39.40% of total ordinary shares) and n. 5,316,241 special shares (equal to 100% of the total shares of this category).
** On 27 July 2020, the shareholder Augusto, in the context of updating the communication pursuant to art. 120 of the Consolidated Law on Finance following the completion of the capital increase, reserved for the subscription by Augusto, approved by the extraordinary Shareholders’ Meeting of Aedes on 18 June 2020 and executed on 24 July 2020, confirmed to the Company that Augusto is legitimate owner of additional n. 5,020,618 Aedes SIIQ SpA ordinary shares, equal to 12.54% of the total share capital of Aedes, originally deposited with an English intermediary and against which emerged, also following the outcome of legal initiatives initiated by Augusto, illegitimate disposals , in nature and in favor of recipients yet to be ascertained. In particular, Augusto has reported that he is not yet able to assess whether the aforementioned Aedes shares are deposited in other accounts that are in any case attributable to the depositary intermediary or if they have been, in whole or in part, definitively sold to third parties.
Augusto consequently communicated that at present he is unable to exercise the rights relating to the aforementioned no. 5,020,618 Aedes ordinary shares and a state of uncertainty remains regarding the recoverability of their availability. The shareholder Augusto also represented to the Company that, in the event of a positive outcome of the affair, Augusto would recover the legitimate availability of its equity investment equal to 60.89% of the total share capital of Aedes and 54.9% of the share capital represented from ordinary shares, without which an obligation to promote the takeover bid can result.
Top Management
